The rising cases of urinary tract infections, which lead to overactivity of the detrusor urinae muscle and involuntary contractions in the bladder, are primarily driving the overactive bladder market.

1. Overactive Bladder
Market Research
Report 2023-2033

2. ABOUT IMARC
2
International Market Analysis Research and Consulting Group is a
leading adviser on management strategy and market research
worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their
most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific,
economic and technological developments for business leaders in
pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel and tourism,
nanotechnology and novel processing methods are at the top of
the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into
the dynamics of companies and markets with close cooperation at
all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient
organizations, and secure lasting results.

3. Report Description and Highlights
Overactive Bladder Market 2023-2033
IMARC Group has recently released a report titled “Overactive Bladder Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future
Forecast (2023-2033)” that presents a comprehensive assessment of the overactive bladder market size, latest trends, and growth forecast. The
report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as
an in-depth analysis of the disease landscape, market scenario, and growth trends. Furthermore, the report offers an analysis of competitors,
regional markets, and recent advancements in the global market. It also sheds light on crucial segments and market drivers, along with
challenges faced by industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the overactive
bladder market.
Overactive bladder (OAB) refers to a medical condition that is marked by a sudden, uncontrollable urge to urinate. The common symptoms of
this ailment include a difficult-to-control need to pee, frequent urination, urinary incontinence, nocturia, etc. If the disease progresses, an
individual may also experience disrupted sleep, infections, fatigue, depression, skin problems, etc. The diagnosis of OAB involves a complete
physical examination, evaluation of the patient’s medical history, urine test, post-void residual (PVR) examination, bladder ultrasound, and
cystoscopies.
3

4. Report Description and Highlights
Overactive Bladder Market Trend:
The rising cases of urinary tract infections, which lead to overactivity of the detrusor urinae muscle and involuntary contractions in the
bladder, are primarily driving the overactive bladder market. Moreover, the increasing instances of aging-related cognitive decline that
make it difficult for the bladder to comprehend the signals it gets from the brain are also augmenting the market growth. Additionally, the
escalating application of effective drugs, including antimuscarinics and beta-3 agonists, which can help the bladder muscle relax and
increase its urine retention and emptying capacity, is creating a positive outlook for the market.
Furthermore, the inflating utilization of neuromodulation therapy to improve and manage OAB, as this approach stimulates electrical
pulses between the brain neurons and the bladder to ensure normal functioning of the bladder, is acting as another significant growth-
inducing factor. Additionally, the rising popularity of conservative measures, such as lifestyle modification and pelvic floor physical therapy,
for managing the condition since they can slow down the disease progression, ease symptoms, and enhance the quality of life in patients,
is anticipated to propel the overactive bladder market in the coming years.
Request a Sample Report: https://www.imarcgroup.com/overactive-bladder-market/requestsample
4

5. Report Description and Highlights
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
• Base Year: 2022
• Historical Period: 2017-2022
• Market Forecast: 2023-2033
Countries Included:
• United States
• Germany
• France
5

6. Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Overactive Bladder market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Overactive Bladder market
• Reimbursement scenario in the market
• In-market and pipeline drugs
6

7. Report Description and Highlights
In-Market Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Regulatory Status
View Report TOC, Figures and Tables: https://www.imarcgroup.com/overactive-bladder-market
7

8. Key Questions Answered in the Report
1. How has the Overactive Bladder Market performed so far and how will it perform in the coming years?
2. What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
3. What was the country-wise size of the Overactive Bladder Market across the seven major markets in 2022 and what will it look like in
2033?
4. What is the growth rate of the Overactive Bladder Market across the seven major markets and what will be the expected growth over
the next ten years?
5. What are the key unmet needs in the market?
8

9. Table of
Contents

10. Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
10

11. Table of Contents
4 Overactive Bladder - Introduction
4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (2017-2022) and Forecast (2023-2033)
4.4 Market Overview (2017-2022) and Forecast (2023-2033)
4.5 Competitive Intelligence
5 Overactive Bladder - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/overactive-bladder-
market/toc
11

12. Partial List Of Our Clients
12

13. OUR CLIENTS
13

14. Disclaimer
14
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis
Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or
in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including
photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information
and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting
makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts
no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and
Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.